Supports Vitality, Libido & Performance (Bremelanotide). Enhance sexual desire, arousal, and overall intimate performance with PT‑141 — a clinically studied peptide that activates central nervous system pathways for vitality and confidence.

✔️ Melanocortin Receptor Agonist: PT‑141 (Bremelanotide) activates melanocortin receptors (MC3R & MC4R) in the brain to stimulate libido and arousal at the neurological level rather than just via blood flow.
✔️ Central Nervous System Action: Works through brain pathways controlling desire and sexual motivation, making it distinct from traditional ED medications.
✔️ Rapid Onset: Effects typically begin within 30–60 minutes and can last several hours, supporting spontaneous use.
✔️ FDA‑Recognized Option: PT‑141 is FDA‑approved under the brand name Vyleesi for treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women.
✔️ Non‑Hormonal Mechanism: Does not directly alter hormone levels like testosterone but supports sexual function through neurochemical pathways.